Product Information
KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.5524 per ML under NDC 00409379625. Its NADAC has been published 82 times since Mar 12, 2025.
FDA first approved this application on Jun 5, 1997. Its Orange Book therapeutic-equivalence code is AP.
Strength
60 mg/2mL
Manufacturer
Hospira Inc.NDC
00409379625
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA074802FDA Approved
6/5/1997
TE Code
AP
On Market Since
10/30/2015
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 82 times since Mar 12, 2025, and over the history we have for it it has declined 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5524 per ML |
|---|---|
| All-time high | $0.6484 (Apr 16, 2025) |
| All-time low | $0.4543 (Feb 18, 2026) |
| 52-week high | $0.5738 |
| 52-week low | $0.4543 |
| Median price | $0.5335 |
| Average price | $0.5438 |
| Largest weekly change | +10.9% (Sep 23, 2026) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
KETOROLAC TROMETHAMINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.5524 per ML (NDC 00409379625), effective Sep 30, 2026.
How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 11.6%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?
Since Mar 12, 2025, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $0.6484 (Apr 16, 2025), with a median of $0.5335 per ML.
Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOROLAC 60 MG/2 ML VIAL, is $0.4980 per ML — about 10% below KETOROLAC 60 MG/2 ML VIAL.
Who manufactures KETOROLAC 60 MG/2 ML VIAL?
KETOROLAC 60 MG/2 ML VIAL (NDC 00409379625) is labeled by Hospira Inc., and CMS classifies it as a generic product.